ANNX
Price
$5.33
Change
-$0.01 (-0.19%)
Updated
Aug 12 closing price
Capitalization
874.92M
4 days until earnings call
Intraday BUY SELL Signals
DYN
Price
$26.17
Change
-$0.54 (-2.02%)
Updated
Aug 12 closing price
Capitalization
4.89B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANNX vs DYN

ANNX vs DYN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANNX vs. DYN commentary
Aug 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and DYN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2026
Stock price -- (ANNX: $5.33 vs. DYN: $26.17)
Brand notoriety: ANNX and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 66% vs. DYN: 59%
Market capitalization -- ANNX: $874.92M vs. DYN: $4.89B
ANNX [@Biotechnology] is valued at $874.92M. DYN’s [@Biotechnology] market capitalization is $4.89B. The market cap for tickers in the [@Biotechnology] industry ranges from $133.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANNX and DYN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while DYN’s TA Score has 3 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 6 bearish.
  • DYN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DYN is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -0.74% price change this week, while DYN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.40%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was +2913.54%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 17, 2026.

DYN is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (+2.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($4.89B) has a higher market cap than ANNX($875M). DYN YTD gains are higher at: 33.793 vs. ANNX (6.175). ANNX has higher annual earnings (EBITDA): -202.46M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. ANNX (225M). ANNX has less debt than DYN: ANNX (25.4M) vs DYN (219M). ANNX (0) and DYN (0) have equivalent revenues.
ANNXDYNANNX / DYN
Capitalization875M4.89B18%
EBITDA-202.46M-502.36M40%
Gain YTD6.17533.79318%
P/E RatioN/AN/A-
Revenue00-
Total Cash225M898M25%
Total Debt25.4M219M12%
FUNDAMENTALS RATINGS
ANNX vs DYN: Fundamental Ratings
ANNX
DYN
OUTLOOK RATING
1..100
939
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4536
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANNX's Valuation (34) in the null industry is in the same range as DYN (44) in the Electric Utilities industry. This means that ANNX’s stock grew similarly to DYN’s over the last 12 months.

DYN's Profit vs Risk Rating (88) in the Electric Utilities industry is in the same range as ANNX (100) in the null industry. This means that DYN’s stock grew similarly to ANNX’s over the last 12 months.

DYN's SMR Rating (99) in the Electric Utilities industry is in the same range as ANNX (99) in the null industry. This means that DYN’s stock grew similarly to ANNX’s over the last 12 months.

DYN's Price Growth Rating (36) in the Electric Utilities industry is in the same range as ANNX (45) in the null industry. This means that DYN’s stock grew similarly to ANNX’s over the last 12 months.

DYN's P/E Growth Rating (100) in the Electric Utilities industry is in the same range as ANNX (100) in the null industry. This means that DYN’s stock grew similarly to ANNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANNXDYN
RSI
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDAX24.260.30
+1.25%
TDAQ Lift ETF
QQH84.920.47
+0.56%
HCM Defender 100 Index ETF
BOXX117.820.02
+0.02%
Alpha Architect 1-3 Month Box ETF
SIXL39.64N/A
N/A
ETC 6 Meridian Low Beta Eq Strat ETF
MLDR48.22N/A
N/A
Global X Intermediate-Term Trsy Lddr ETF

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with NUVB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-0.19%
NUVB - ANNX
40%
Loosely correlated
+0.78%
VYGR - ANNX
39%
Loosely correlated
N/A
DYN - ANNX
38%
Loosely correlated
-2.02%
DMAC - ANNX
38%
Loosely correlated
-0.44%
NRIX - ANNX
38%
Loosely correlated
+2.58%
More